Table 3

Summary of the two-biomarker model for diagnosis of ARDS in the derivation cohort

(upper and lower quartiles)
OR for ARDS*95% CIp
RAGE (1846 vs 656)2.3821.638 to 3.464<0.001
Ang-2 (6128 vs 2935)1.8901.322 to 2.702<0.001
  • *OR for ARDS comparing upper quartile (75th percentile) to lower quartile (25th percentile).

  • Ang-2, angiopoietin-2; ARDS, acute respiratory distress syndrome; RAGE, receptor for advanced glycation endproducts.